Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes

Advances in Experimental Medicine and Biology

Volumn 624, Issue , 2008, Pages 55-71

  Bischoff Ferrari, Heike A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; BLOOD PRESSURE REGULATION; BONE DENSITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CLINICAL TRIAL; DENTAL HEALTH; DRUG MECHANISM; FALL RISK; FRACTURE; GINGIVITIS; HUMAN; HYPERTENSION; NURSING HOME; OUTCOME ASSESSMENT; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; DRUG EFFECT; FALLING; HEALTH CARE POLICY; HEALTH STATUS; LOCOMOTION; NEOPLASM; TREATMENT OUTCOME; UTILIZATION REVIEW; VITAMIN D DEFICIENCY;

ACCIDENTAL FALLS; BONE DENSITY; FRACTURES, BONE; HEALTH STATUS; HUMANS; HYPERTENSION; LOCOMOTION; NEOPLASMS; NURSING HOMES; NUTRITION POLICY; PERIODONTAL DISEASES; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 42949125874     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-77574-6_5     Document Type: Review

References (147)

1. BischoflF-Ferrari HA, Giovannucci E, Willett WC et al. Estimation of optimal serum concentrations of 25-hydroxysdtamin D for multiple health outcomes. Am J Clin Nutr 2006; 84(1): 18-28.
2. Freaney R, McBrinn Y, McKenna MJ. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr 1993; 58(2): 187-91.
3. Dawson-Hughes B, Stern DT, Shipp CC et al. EflFect of lowering dietary calcium intake on fractional whole body calcium retention. J Clin Endocrinol Metab 1988; 67(l):62-8.
4. Kitamura N, Shigeno C, Shiomi K et al. Episodic fluctuation in scrum intact parathyroid hormone concentration in men. J Clin Endocrinol Metab 1990; 70(l):252-63.
5. Bischoff H, Stahelin HB, Vogt P et al. Immobility as a major cause of bone remodeling in residents of a long-stay geriatric ward. Calcif Tissue Int 1999; 64(6):485-9.
6. Lips P, Wiersinga A, van Ginkel FC et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988; 67(4):644-50.
7. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351(9105):805-6.
8. Peacock M. Effects of calcium and vitamin D insufficiency on the skeleton. Osteoporos Int 1998; 8(Suppl 2):S45-51.
9. Chapuy MC, Preziosi P, Maamer M et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7(5):439-43.
10. Dawson-Hughes B, Harris SS, Dallal GE. Plasma calcidiol, season and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997; 65(1):67-71.
11. Krall EA, Sahyoun N, Tannenbaum S et al. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 1989; 321(26): 1777-83.
12. Bischoff-Ferrari HA, Willett WC, Wong JB et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293(18):2257-64.
13. Raiten DJ, Picciano MF. Vitamin D and health in the 21st century: bone and beyond. Executive summary. Am J CUn Nutr 2004; 80(6 Suppl):1673S-7S.
14. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332(12):767-73.
15. Dawson-Hughes B, Harris SS, Krall EA et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337(10):670-6.
16. Chapuy MC, Arlot ME, Duboeuf F ct al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327(23): 1637-42.
17. Ooms ME, Roos JC, Bezemer PD et al. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995; 80(4): 1052-8.
18. BischoflF-Ferrari HA, Dietrich T, Orav EJ et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116(9):634-9.
19. Jackson RD, LaCroix AZ, Gass M et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354(7) :669-83.
20. Lips P, Duong T, Oleksik A et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86(3): 1212-21.
21. Theiler R, Stahelin HB, Tyndall A et al. Calcidiol, calcitriol and parathyroid hormone serum concentrations in institutionalized and ambulatory elderly in Switzerland. Int J Vitam Nutr Res 1999; 69(2):96-105.
22. Kinyamu HK, Gallagher JC, Balhorn KE et al. Serum vitamin D metabolites and calcium absorption in normal yoimg and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 1997; 65(3):790-7.
23. Holick MF, Shao Q? Liu WW et al. The vitamin D content of fortified milk and infant formula. N Engl J Med 1992; 326(18):1178-81.
24. Grant AM, Avenell A, Campbell MK et al. Oral vitamin D3 and calciimi for secondary prevention of low-traimia fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365(9471): 1621-8.
25. Porthouse J, Cockayne S, King C et aL Randomised controlled trial of calciiun and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. Bmj 2005; 330(7498): 1003.
26. Lips P, Chapuy MC, Dawson-Hughes B et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999; 9(5):394-7.
27. Gallagher JC, Kinyamu HK, Fowler SE et al. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 1998; 13(3):475-82.
28. Heaney RP, Barger-Lux MJ, DoweU MS et al. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 1997; 82(12):4111-6.
29. Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest 1996; 26:436-442.
30. Boland R. Role of vitamin D in skeletal muscle function. Endocrine Reviews 1986; 7:434-447.
31. Glerup H, Mikkelsen K, Poulsen L et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 2000; 66(6) :419-24.
32. Birge SJ, Haddad JG. 25-hydroxycholecalciferol stimulation of muscle mctabohsm. J Clin Invest 1975; 56(5):1100-7.
33. Bischoff HA, Stahelin HB, Dick W et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18(2):343-51.
34. Sorensen OH, Lund B, Saltin B et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Colch) 1979; 56(2):157-61.
35. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88(12):5766-72.
36. Sharkey JR, Giuliani C, Haines PS et al. Summary measure of dietary musculoskeletal nutrient (calcium, vitamin D, magnesium and phosphorus) intakes is associated with lower-extremity physical performance in homebound elderly men and women. Am J Clin Nutr 2003; 77(4):847-56.
37. Bischoff-Ferrari HA, Dawson-Hughes B, Willett CW et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291(16):1999-2006.
38. Pfeifer M, Begerow B, Minne HW et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000; 15(6):1113-8.
39. Gallagher JC, Fowler SE, Detter JR et al. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 2001; 86(8):3618-28.
40. Dukas L, Bischoff HA, Lindpaintner LS et al. Alfacalcidol Reduces the Number of Fallers in a Community- Dwelling Elderly Population with a Minimum Calcium Intake of More Than 500 Mg Daily. J Am Geriatr Soc 2004; 52(2):230-236.
41. Graafmans WC, Ooms ME, Hofstee HM et al. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996; 143(11):1129-36.
42. Broe KE, Chen TC, Weinberg J et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007; 55(2):234-9.
43. BischoflF-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006; 166(4) :424-30.
44. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 1985; 260(15):8882-91.
45. Bischoff HA, Borchers M, Gudat F et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33(1): 19-24.
46. Endo I, Inoue D, Mitsui T et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003; 144(12):5138-44 Epub.
47. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inaaive persons aged 60 y. Am J Clin Nutr 2004; 80(3):752-8.
48. Zehnder D, Bland R, WilUams MC et al. Extrarenal expression of 25-hydroxyvitamin d(3)-l alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86(2):888-94.
49. Wicherts IS, Schoor Van NM, Boeke AJP et al. Vitamin D deficiency and neuromuscular performance in the Longitudinal Ading Study Amsterdam (LASA). JBMR 2005; 20 Suppl 1, abstract 1134:S35.
50. Guralnik JM, Ferrucci L, Simonsick EM et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332(9):556-61.
51. Seeman TE, Charpentier PA, Berkman LF et al. Predicting changes in physical performance in a high-functioning elderly cohort: MacArthur studies of successful aging. J Gerontol 1994; 49(3): M97-108.
52. Wicherts IS, van Schoor NM, Boeke AJ et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007; 6:6.
53. Ong G. Periodontal reasons for tooth loss in an Asian population. J Clin Periodontol 1996; 23:307-309.
54. Phipps KR, Stevens VJ. Relative contribution of caries and periodontal disease in adult tooth loss for an HMO dental population. J Pub Health Dent 1995; 55:250-252.
55. Stabholz A, Babayof I, Mersel A et al. The reasons for tooth loss in geriatric patients attending two surgical clinics in Jerusalem, Israel. Gerodontology 1997; 14:83-88.
56. Warren JJ, Watkins CA, Cowen HJ et al. Tooth loss in the very old: 13-15-year incidence among elderly lowans. Comm Dent Oral Epidemiol 2002; 30:29-37.
57. Ritchie CS, Joshipura K, Hung HC et al. Nutrition as a mediator in the relation between oral and systemic disease: associations between specific measures of adult oral health and nutrition outcomes. Crit Rev Oral Biol Med 2002; 13:291-300.
58. Marshall TA, Warren JJ, Hand JS et al. Oral health, nutrient intake and dietary quality in the very old. J Am Dent Assoc 2002; 133(10): 1369-79.
59. Norlen P, Stecn B, Birkhed D et al. On the relations between dietary habits, nutrients and oral health in women at the age of retirement. Acta Odontol Scand 1993; 51(5):277-84.
60. Payne JB, Reinhardt RA, Nummikoski PV et al. The association of cigarette smoking with alveolar bone loss in postmenopausal females. J Clin Periodontol 2000; 27(9):658-64.
61. Payne JB, Reinhardt RA, Nummikoski PV et al. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 1999; 10(l):34-40.
62. Tezal M, Wactawski-Wende J, Grossi SG et al. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000; 71(9): 1492-8.
63. Wactawski-Wende J, Grossi SG, Trevisan M et al. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996; 67(10 Suppl): 1076-84.
64. Krall EA, Dawson-Hughes B, Papas A et al. Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int 1994; 4(2): 104-9.
65. Bando K, Nitta H, Matsubara M et al. Bone mineral density in periodontally healthy and edentulous postmenopausal women. Ann Periodontol 1998; 3(l):322-6.
66. Krall EA, Garcia RI, Dawson-Hughes B. Increased risk of tooth loss is related to bone loss at the whole body, hip and spine. Calcif Tissue Int 1996; 59(6):433-7.
67. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13(4):719-64.
68. DAmbrosio D, Cippitelli M, Cocciolo MG et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101(l):252-62.
69. Dietrich T, Nunn M, Dawson-Hughes B et al. Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J CUn Nutr 2005; 82(3):575-80.
70. Dietrich T, Joshipura KJ, Dawson-Hughes B et al. Association between serum concentrations of 25-hydro3cyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 2004; 80(1): 108-13.
71. Krall EA, Wchler C, Garcia RI et al. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 2001; lll(6):452-6.
72. Chen TC, Persons K, Liu WW et al. The antiproliferative and diffcrentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J Invest Dermatol 1995; 104(1): 113-7.
73. Bises G, Kallay E, Weiland T et al. 25-hydroxyvitamin D3-lalpha-hydroxylase expression in normal and maUgnant human colon. J Histochem Cytochem 2004; 52(7):985-9.
74. Garland CF, Gorham ED, Mohr SB et al. Vitamin D and prevention of breast cancer: Pooled analysis. J Steroid Biochem Mol Biol 2007; 103(3-5):708-ll.
75. Gorham ED, Garland CF, Garland FC et al. Optimal vitamin D status for colorectal cancer prevention a quantitative meta analysis. Am J Prev Med 2007; 32(3):210-6.
76. Bostick RM, Potter JD, Sellers TA et al. Relation of calcium, vitamin D and dairy food intake to incidence of colon cancer in older women. American Journal of Epidemiology 1993; 137:1302-1317.
77. Kearney J, Giovannucci E, Rimm EB et al. Calcium, vitamin D and dairy foods and the occurrence of colon cancer in men. American Journal of Epidemiology 1996; 143:907-917.
78. Martinez ME, Giovannucci EL, Colditz GA et al. Calciimi, vitamin D and the occurrence of colorectal cancer among women. Journal of the National Cancer Institute 1996; 88:1375-1382.
79. McCullough ML, Robertson AS, Rodriguez C et al. Calcium, vitamin D, dairy products and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes and Control 2003; 14:1-12.
80. Marcus PM, Newcomb PA. The association of calcium and vitamin D and colon and rectal cancer in Wisconsin women. International Journal of Epidemiology 1998; 27:788-793.
81. Zheng W, Anderson KE, Kushi LH et al. A prospective cohort study of intake of calcium, vitamin D and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 1998; 7:221-225.
82. Kampman E, Slattery ML, Caan B et al. Calcium, vitamin D, sunshine exposures, dairy products and colon cancer risk (United States). Cancer Causes and Control 2000; 11:459-466.
83. Holt PR, Arber N, Halmos B et al. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiology, Biomarkers and Prevention 2002; 11:113-119.
84. Meggouh F, Lointier P, Saez S. Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Research 1991; 51(4): 1227-1233.
85. Giuliano AR, Franceschi RT, Wood RJ. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Archives of Biochemistry and Biophysics 1991; 285(2):261-269.
86. Vandewalle B, Adenis A, Homcz L et al. 1,25-dihydroxyvitamin D3 receptors in normal and maUgnant human colorectal tissues. Cancer Letters 1994; 86(l):67-73.
87. Zhao X, Feldman D. Regulation of vitamin D receptor abundance and responsiveness during diflFerentiation of HT-29 human colon cancer cells. Endocrinology 1993; 132(4): 1808-1814.
88. Wactawski-Wende J, Kotchen JM, Anderson GL et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354(7) :684-96.
89. Giovannucci E. Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 2006; 354(21):2287-8; author reply 2287-8.
90. Martinez ME, Giovannucci EL, Colditz GA et al. Calcium, vitamin D and the occurrence of colorectal cancer among women. J Natl Cancer Inst 1996; 88(19):1375-82.
91. Feskanich D, Ma J, Fuchs CS et al. Plasma vitamin d metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13(9):1502-8.
92. Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98(7):451-9.
93. The Vitamin D Workshop 2004. J Steroid Biochem Mol Biol 2005; 97(l-2):l-2. Epub.
94. Heancy RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 15:15.
95. Bouillon R, Moody T, Sporn M et al. NIH deltanoids meeting on Vitamin D and cancer. Conclusion and strategic options. J Steroid Biochem Mol Biol 2005; 97(l-2):3-5. Epub .
96. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure diflPerences. Hypertension 1997; 30(2 Pt l):150-6.
97. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodiimi metabolism. Ann Intern Med 1986; 105(5):649-54.
98. Lind L, Wcnglc B, Wide L ct al. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989; 2(l):20-5.
99. Lind L, Hanni A, Lithell H et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8(9):894-901.
100. Kristal-Boneh E, Froom P, Harari G et al. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997; 30(5): 1289-94.
101. Burgess ED, Hawkins RG, Watanabe M. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990; 3(12 Pt l):903-5.
102. Imaoka M, Morimoto S, Kitano S et al. Calcium metaboHsm in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol 1991; 18(9):631-41.
103. Pfeifer M, Begerow B, Minne HW et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86(4):1633-7.
104. Krause R, Buhring M, HopfenmuUer W et al. Ultraviolet B and blood pressure. Lancet 1998; 352(9129):709-10.
105. Koh E, Morimoto S, Fukuo K et al. 1,25-Dihydroxyvitamin D3 binds specifically to rat vascular smooth muscle cells and stimulates their proliferation in vitro. Life Sci 1988; 42(2) :215-23.
106. Merke J, Hofmann W, Goldschmidt D et al. Demonstration of l,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 1987; 41(2): 112-4.
107. Hariharan S, Hong SY, Hsu A et al. Effect of 1,25-dihydroxyvitamin D3 on mesangial cell proliferation. J Lab Clin Med 1991; 117(5):423-9.
108. Mitsuhashi T, Morris RC Jr, Ives HE. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991; 87(6): 1889-95.
109. Nobiling R, Muntcr K, Buhrlc CP et al. Influence of pulsatile perfusion upon renin release from the isolated perfused rat kidney Pflugers Arch 1990; 415 (6) :713-7.
110. Jelinek J, Hackenthal E, Hackenthal R. Role of the renin-angiotensin system in the adaptation to high salt intake in immature rats. J Dev Physiol 1990; l4(2):89-94.
111. Li YC, Kong J, Wei M et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110(2):229-38.
112. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003; 88(2):327-31.
113. Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension. Hypertension 2007; 19:19.
114. Intakes SCotSEoDR. Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press, 1997.
115. Heaney RP, Davies KM, Chen TC et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77(1):204-10.
116. Chel VG, Ooms ME, Popp-Snijders C et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 1998; 13(8):1238-42.
117. Vieth R, Kimball S, Hu A et al. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 meg (4000 lU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004; 3:8.
118. Tangpricha V, Pearce EN, Chen TC et al. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002; 112:659-62.
119. Barger-Lux MJ, Heaney RP, Dowell S et al. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998; 8(3):222-30.
120. Dawson-Hughes B. Impact of vitamin D and calcium on bone and mineral metabolism in older adults. In: Hohck MF ed. Biologic Effects of Light 2001. Boston, MA: Kluwer Academic Publishers, 2002:175-83.
121. Vieth R, Chan PC, MacFarlanc GD. Eflicacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73(2):288-94.
122. Heaney RP, Dowell MS, Hale CA et al. Calcium absorption varies within the reference range for sermn 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22(2): 142-6.
123. Steingrimsdottir L, Gunnarsson O, Indridason OS et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency and calcium intake. JAMA 2005; 294(18):2336-41.
124. Ray NF, Chan JK, Thamer M et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12(l):24-35.
125. Melton LJ, 3rd, Gabriel SE et al. Cost-equivalence of different osteoporotic fractures. Osteoporos Int 2003; 14(5):383-8 Epub.
126. Tabcnsky A, Duan Y, Edmonds J ct al. The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures. J Bone Miner Res 2001; 16(6):1101-7.
127. McKenna MJ. DiflFerences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93(l):69-77.
128. Webb AR, Kline L, HoUck ME Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67(2):373-8.
129. Parikh SJ, Edelman M, Uwaifo GI et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89(3): 1196-9.
130. Looker AC, Dawson-Hughes B, Calvo MS et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30(5) :771-7.
131. Nesby-O'Dell S, Scanlon KS, Cogswell ME et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002; 76(l):187-92.
132. Hathcock JN, Shao A, Vieth R et al. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85(1):6-18.
133. Yates AA. Process and development of dietary reference intakes: basis, need and application of recommended dietary allowances. Nutr Rev 1998; 56(4 Pt 2):S5-9.
134. Haddock L, Corcino J, Vazquez MD. 25(OH)D serum levels in the normal Puerto Rican population and in subjects with tropical sprue and paratyroid disease. Puerto Rico Health Sci J 1982; 1:85-91.
135. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferoL J Clin Endocrinol Metab 1971; 33(6):992-5.
136. Gertncr JM, Domenech M. 25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. J Clin Pathol 1977; 30(2):l44-50.
137. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 1999; 69(5):842-56.
138. Grant WB, Holick ME Benefits and requirements of vitamin D for optimal health: a review. Altem Med Rev 2005; 10(2):94-111.
139. Theiler R, Stahelin HB, Kranzlin M et al. Influence of physical mobility and season on 25-hydroxyvitamin D-parathyroid hormone interaction and bone remodelling in the elderly. Eur J Endocrinol 2000; 143(5):673-9.
140. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61(suppl):638S-45S.
141. Lips P, Graafmans WC, Ooms ME et al. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124(4):400-6.
142. Meyer HE, Smedshaug GB, Kvaavik E et al. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002; 17(4):709-15.
143. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortahty in men and women living in the community: randomised double blind controlled trial. Bmj 2003; 326(7387):469.
144. Chapuy MC, Pamphile R, Paris E et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13(3):257-64.
145. Gunter EW, Lewis BL, Konkikowski SM. Laboratory Methods Used for the Third National Health and Nutrition Examination Survey (NHANES II), 1988-1994 (CD-ROM). Hyattsville, MD: Centers for Disease Control and Prevention [avaiable from National Information Service, Springfield, VA] 1996.
146. Falch JA, Oftebro H, Haug E. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein. J Chn Endocrinol Metab 1987; 64(4):836-41.
147. Bischoff-Ferrari HA. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 2007; 18(4):401-7.